7Baggers
 Longeveron announces resignations of two board members By Investing.com  Investing.com Australia Thu, 13 Nov 2025 03:03:52 GMT
 Longeveron granted U.S. patent for administration of MSCs  TipRanks Wed, 12 Nov 2025 18:17:21 GMT
 Longeveron Announces Resignation of Board Members  TipRanks Wed, 12 Nov 2025 12:12:36 GMT
 Longeveron announces resignations of two board members  Investing.com Wed, 12 Nov 2025 11:44:20 GMT
 Longeveron Inc. (NASDAQ:LGVN) Q3 2025 Earnings Call Transcript  Insider Monkey Thu, 06 Nov 2025 13:20:11 GMT
 Longeveron Inc. Earnings Call: Mixed Sentiments Amid Clinical Progress  The Globe and Mail Thu, 06 Nov 2025 01:30:00 GMT
 Longeveron Posts Bigger Losses But Analysts Still See Upside  Finimize Wed, 05 Nov 2025 21:12:53 GMT
 longeveron inc. reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 04:40:37 GMT
 transcript : longeveron inc., q3 2025 earnings call, nov 04, 2025  MarketScreener Wed, 05 Nov 2025 02:20:54 GMT
 longeveron reports q3 eps (39c), consensus (26c)  TipRanks Tue, 04 Nov 2025 22:11:11 GMT
 Cellular therapy developer Longeveron's Q3 net loss widens  TradingView Tue, 04 Nov 2025 21:53:25 GMT
 longeveron inc. (lgvn) q3 fy2025 earnings call transcript  Yahoo Finance Tue, 04 Nov 2025 21:30:00 GMT
 Longeveron Inc. Reports Q3 2025 Financial Results  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2025 Result  Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
 longeveron posts bigger losses but analysts still see upside  Finimize Mon, 03 Nov 2025 08:00:00 GMT

Longeveron Inc.
(NASDAQ:LGVN) 

LGVN stock logo

Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cel...

Founded: 2014
CEO: Geoffrey Green  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends